Source: Virtual Congress 2021 – New insights into nontuberculous mycobacteria disease: from diagnosis to treatment



Rating:

Share or cite this content

Citations should be made in the following way:
E. Cambau (Paris, France). The challenges of diagnosing NTM. Virtual Congress 2021 – New insights into nontuberculous mycobacteria disease: from diagnosis to treatment

Member's Comments

No comment yet.

Related content which might interest you: Advances in the diagnosis of mycobacteria infections and challenges of drug susceptibility testing Source: International Congress 2019 – New guidelines for treatment of nontuberculous mycobacterial pulmonary disease Year: 2019 The impact of new ATS/IDSA guideline for nontuberculous mycobacterial disease on the diagnosis of nontuberculous mycobacterial lung disease in Korea Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi Year: 2008 Beyond pulmonary nontuberculous mycobacteria disease: do extra-pulmonary forms represent an emerging clinical and public health threat? Source: ERJ Open Res, 3 (3) 00091-2017; 10.1183/23120541.00091-2017 Year: 2017 Unresolved issues in treatment outcome definitions for nontuberculous mycobacterial pulmonary disease Source: Eur Respir J, 53 (5) 1801636; 10.1183/13993003.01636-2018 Year: 2019 New international (ATS/ERS/ESCMID/IDSA) guidelines for the management of NTM pulmonary diseases Source: ERS Webinar 2020: New international (ATS/ERS/ESCMID/IDSA) guidelines for the management of NTM pulmonary diseases Year: 2020 Pulmonary aspergillosis – diagnostic and therapeutic challenges Source: Eur Respir J 2005; 26: Suppl. 49, 170s Year: 2005 The management of non-tuberculous mycobacteria Source: International Congress 2016 – New therapies for chronic respiratory infections Year: 2016 Pathogenicity of NTM: new developments Source: Annual Congress 2007 - Nontuberculous mycobacteria (NTM): a slow-growing challenge Year: 2007 Limitations of immune-based diagnostics in patients suspected for pulmonary tuberculosis Source: Annual Congress 2009 - Frontiers in the diagnosis of tuberculosis Year: 2009 Diagnosis, classification and epidemiology of pulmonary nontuberculous mycobacterial disease Source: Eur Respir Monogr 2018; 81: 204-221 Year: 2018 Non-tuberculous mycobacteria (NTM) in bronchiectasis - a difficult management problem Source: Eur Respir J 2003; 22: Suppl. 45, 515s Year: 2003 Diagnosing and treating paediatric tuberculosis infections Source: International Congress 2018 – PG13 Challenges in the treatment of tuberculosis Year: 2018 Identification and management of non tuberculous mycobacteria in extra pulmonary cases in clinical practice Source: Annual Congress 2009 - Extrapulmonary tuberculosis and non-tuberculous-mycobacteria (NTM) infections Year: 2009 Bronchoscopy is useful for diagnosing smear-negative tuberculosis in HIV-infected patients Source: Eur Respir J 2010; 36: 446 Year: 2010 From detection of nontuberculous mycobacteria (NTM) in pulmonary specimens to pulmonary infections Source: Eur Respir J 2004; 24: Suppl. 48, 420s Year: 2004 Management of pulmonary nontuberculous mycobacteria disease Source: Eur Respir Monogr 2018; 81: 222-237 Year: 2018 Determining the role of Xpert® MTB/RIF in diagnosing tuberculosis in postmortem tissues Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015 Impact of diagnostic pitfalls on the management of pulmonary sarcoidosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease Year: 2012